FINVX | LIRRX | FINVX / LIRRX | |
Total Expense Ratio | 0.01 | 1.24 | 1% |
Annual Report Gross Expense Ratio | 0.01 | 1.24 | 1% |
Fund Existence | 16 years | 17 years | - |
Gain YTD | 34.480 | 26.983 | 128% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.2B | 461M | 3,514% |
Annual Yield % from dividends | 3.50 | 2.54 | 138% |
Returns for 1 year | 22.47 | 17.36 | 129% |
Returns for 3 years | 109.69 | 83.75 | 131% |
Returns for 5 years | 127.39 | 74.46 | 171% |
Returns for 10 years | 125.09 | 81.42 | 154% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 69.15 | 0.84 | +1.23% |
Janus Henderson Global Life Sciences T | |||
HFMDX | 22.93 | 0.26 | +1.15% |
Hennessy Cornerstone Mid Cap 30 Inv | |||
LSVVX | 15.16 | 0.13 | +0.86% |
LSV Conservative Value Equity | |||
ERBIX | 20.47 | 0.12 | +0.59% |
Eaton Vance Equity Strategy I | |||
RNPGX | 73.25 | 0.38 | +0.52% |
American Funds New Perspective R6 |